Related Experiment Video
Updated: Mar 27, 2026

Tracking Mouse Bone Marrow Monocytes In Vivo
Published on: February 27, 2015
Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking
Maj-Linda B Selenica1, Patrick Reid2, Gabriela Pena2
1Dept of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.
Abstract:
Inflammation, including microglial activation in the CNS, is an important hallmark in many neurodegenerative diseases. Microglial stimuli not only impact the brain microenvironment by production and release of cytokines and chemokines, but also influence the activity of bone marrow derived cells and blood born macrophage populations. In many diseases including brain disorders and spinal cord injury, researchers have tried to harbor the neuroprotective and repair properties of these subpopulations. Hematopoietic bone marrow derived cells (BMDCs) are of great interest, especially during gene therapy because certain hematopoietic cell subpopulations traffic to the sites of injury and inflammation. The aim of this study was to develop a method of labeling endogenous bone marrow derived cells through intraosseous impregnation of recombinant adeno-associated virus (rAAV) or lentivirus. We utilized rAAV serotype 9 (rAAV-9) or lentivirus for gene delivery of green florescence protein (GFP) to the mouse bone marrow cells. Flow cytometry showed that both viruses were able to efficiently transduce mouse bone marrow cells in vivo. However, the rAAV9-GFP viral construct transduced BMDCs more efficiently than the lentivirus (11.2% vs. 6.8%), as indicated by cellular GFP expression. We also demonstrate that GFP labeled cells correspond to bone marrow cells of myeloid origin using CD11b as a marker. Additionally, we characterized the ability of bone marrow derived, GFP labeled cells to extravasate into the brain parenchyma upon acute and subchronic neuroinflammatory stimuli in the mouse CNS. Viral mediated over expression of chemokine (C-C motif) ligand 2 (CCL2) or intracranial injection of lipopolysaccharide (LPS) recruited GFP labeled BMDCs from the periphery into the brain parenchyma compared to vehicle treated mice. Altogether our findings demonstrate a useful method of labeling endogenous BMDCs via viral transduction and the ability to track subpopulations throughout the body following insult or injury. Alternatively, this method might find utility in delivering therapeutic genes for neuroinflammatory conditions.
Insights
Researchers developed a method to label bone marrow derived cells (BMDCs) using viral vectors for tracking in neuroinflammation. This technique allows monitoring of BMDCs
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Neuroinflammation, including microglial activation, is central to neurodegenerative diseases.
- Bone marrow derived cells (BMDCs) and macrophages are implicated in brain repair and injury responses.
- Targeting BMDCs offers potential for neuroprotection and gene therapy in CNS disorders.
Purpose of the Study:
- To develop and validate a method for labeling endogenous BMDCs using viral vectors for tracking in vivo.
- To assess the efficiency of recombinant adeno-associated virus (rAAV) and lentivirus for gene delivery to mouse bone marrow cells.
- To investigate the migration of labeled BMDCs into the brain parenchyma under neuroinflammatory conditions.
Main Methods:
- Intraosseous impregnation of mouse bone marrow with rAAV serotype 9 (rAAV-9) or lentivirus carrying the green fluorescence protein (GFP) gene.
- Flow cytometry analysis to quantify GFP expression in transduced BMDCs and confirm myeloid origin (CD11b marker).
- Induction of neuroinflammation using viral mediated overexpression of CCL2 or intracranial LPS injection to assess BMDC extravasation into the CNS.
Main Results:
- Both rAAV-9 and lentivirus efficiently transduced mouse BMDCs in vivo, with rAAV-9 showing higher transduction efficiency (11.2% vs. 6.8%).
- GFP-labeled cells were confirmed to be of myeloid origin.
- Neuroinflammatory stimuli (CCL2 or LPS) significantly recruited GFP-labeled BMDCs from the periphery into the mouse brain parenchyma.
Conclusions:
- Viral transduction provides an effective method for labeling endogenous BMDCs.
- This labeling technique enables tracking of BMDCs in the CNS following neuroinflammatory insults.
- The method holds promise for tracking cell migration and potentially delivering therapeutic genes in neuroinflammatory conditions.

